POP-OUT | CLOSE

An Information Portal to 105097 Biological Macromolecular Structures

 
TOMUDEX
 
D16 is found in 10 entries
D16
  •   Chemical Component Summary   Hide
    Name TOMUDEX
    Identifiers N-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)carbonyl]-L-glutamic acid
    (2S)-2-[[5-[methyl-[(2-methyl-4-oxidanylidene-1H-quinazolin-6-yl)methyl]amino]thiophen-2-yl]carbonylamino]pentanedioic acid
    Synonyms ZD1694
    Raltitrexed
    Formula C21 H22 N4 O6 S
    Molecular Weight 458.49 g/mol
    Type non-polymer
    Isomeric SMILES
    InChI
    InChI key IVTVGDXNLFLDRM-HNNXBMFYSA-N
     
  •   Drug Info: DrugBank Hide
    DrugBank ID DB00293   (Stereoisomeric match)
    Name Raltitrexed
    Groups
    • approved
    • investigational
    Description Raltitrexed (brand name Tomudex®) is a chemotherapy drug manufactured AstraZeneca Company, is an antimetabolite used in chemotherapy. It is an inhibitor of thymidylate synthase.
    Synonyms
    • Raltitrexed
    • Tomudex
    • ZD1694
    Brand names Tomudex
    Affected organism Humans and other mammals
    Indication For the treatment of malignant neoplasm of colon and rectum
    Pharmacology Raltitrexed belongs to a group of medicines known as antimetabolites. It is used to treat cancer of the colon and rectum. It may also be used to treat other kinds of cancer, as determined by your doctor. Raltitrexed blocks an enzyme needed by the cell to live. This interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected by raltitrexed, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern.
    Mechanism of action Raltitrexed is an antineoplastic Agents and folic acid antagonists. Raltitrexed inhibits thymidylate synthase (TS) leading to DNA fragmentation and cell death. It is transported into cells via a reduced folate carrier. Inside the cell Raltitrexed is extensively polyglutamated, which enhances thymidylate synthase inhibitory power and duration. Inhibition of this enzyme results in decreased synthesis of thymidine triphosphate which is required for DNA synthesis.
    Route of administration Intravenous
    ATC-Code L01BA03
    AHFS-Code 92:00.00
    CAS number 112887-68-0
    Targets
    Name Sequence search Pharmacological action Actions
    Thymidylate synthase   Search  yes inhibitor
    Folylpolyglutamate synthase, mitochondrial   Search  unknown antagonist
     
Ligand Image